Viewing Study NCT03916094

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-02-28 @ 10:56 PM
Study NCT ID: NCT03916094
Status: COMPLETED
Last Update Posted: 2022-05-05
First Post: 2019-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluate Safety, Tolerability and Pharmacokinetics of HLX22 in Patients With Advanced Solid Tumors Overexpressing HER2
Sponsor: Shanghai Henlius Biotech
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None overexpressing HER2 View